177Lu-PSMA and 177Lu-DOTATATE therapy in a patient with metastatic castration-resistant prostate cancer and neuroendocrine differentiation - Assadi, M; Pirayesh, E; Rekabpour, SJ (Clinical nuclear medicine, 2019)